Literature DB >> 7171475

Experimental production of pulmonary granulomas; II. Age dependency and immune modulation of granuloma production.

Y Hamamoto, K Kinoshita, K Hashimoto, T Matsushita, K Yasuhira.   

Abstract

Endobronchial instillation of Freund's complete adjuvant (FCA) induced epithelioid cell granulomas in the lungs of juvenile rabbits which had been kept free from contamination with the microbiol antigens. The granulomas were named "juvenile granulomas", because, unlike FCA granulomas in adult animals, prior immunization was unnecessary for their induction. The granulomas developed in several weeks with a peak at 14 weeks of age, after which the production decreased gradually. The rate of granuloma production seemed to vary with the acquisition of skin hypersensitivity to tuberculin (OT), suggesting that granuloma production, as well as skin hypersensitivity, is in the category of T-dependent immune reactions. In fact, T-generating lymphoid organs developed in parallel with the dermal and pulmonary reactions. Thus, juvenile rabbits at about 14 weeks of age are most susceptible to the microbial antigens. This susceptibility results in the unexpected production of immune granulomas in response to depot antigens at the site of instillation. The treatment of foetal or neonatal rabbits with FCA markedly suppressed granuloma production in juveniles but not in adults and did suppress but gradually enhanced the tuberculin skin reaction. It is suggested that generation of suppressor T cells is the cause of suppression of juvenile granuloma production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7171475      PMCID: PMC2040764     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Studies on the role of suppressor cells in specific unresponsiveness to DNCB.

Authors:  L Polak
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

2.  B-cell suppression of delayed hypersensitivity reactions.

Authors:  S I Katz; D Parker; J L Turk
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

3.  Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody.

Authors:  R Neta; S B Salvin
Journal:  Cell Immunol       Date:  1973-11       Impact factor: 4.868

4.  Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  F Y Liew
Journal:  Eur J Immunol       Date:  1977-10       Impact factor: 5.532

5.  Suppression of contact sensitivity by T cells in the mouse. I. Demonstration that suppressor cells act on the effector stage of contact sensitivity; and their induction following in vitro exposure to antigen.

Authors:  G L Asherson; M Zembala
Journal:  Proc R Soc Lond B Biol Sci       Date:  1974-11-05

6.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

7.  Modulation of granulomatous hypersensitivity. I. Characterization of T lymphocytes involved in the adoptive suppression of granuloma formation in Schistosoma mansoni-infected mice.

Authors:  S W Chensue; D L Boros
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

8.  Inhibition of tuberculin skin hypersensitivity in guinea pigs by injection of tuberculin and intact tubercle bacilli during fetal life.

Authors:  D W WEISS
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

9.  Occurrence of delayed hypersensitivity during the development of Arthus type hypersensitivity.

Authors:  S B SALVIN
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

10.  Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity.

Authors:  S Morikawa; M Baba; T Harada; A Mitsuoka
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.